DAVID A RAMSAY
CIK 1283292 · EVP, PRESIDENT, DRUG DELIVERY · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.21M
Companies
6
Total Filings
78
Lifetime Open-Market Net
$4.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HALO | EVP, PRESIDENT, DRUG DELIVERY | 4,592 | $82.54 | $379.0K | $0 | 1 | 2026-07-02 |
| HTI | Interim CFO | 364,320 | — | — | -$33.8K | 19 | 2026-04-02 |
| SVRA | Director | 2,533,642 | $5.46 | $13.83M | $3.85M | 39 | 2025-12-19 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | 97,000 | $6.22 | $603.3K | $384.8K | 9 | 2022-01-14 |
| MSTX | Director | — | $8.04 | — | $0 | 4 | 2017-01-23 |
| Savara Inc (ANX) Delisted | Director | 100,000 | — | — | $55.1K | 4 | 2012-07-30 |
Recent Filings · Page 3 of 8
78 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-01 | SVRA | Buy (P) | +100,000 | $141.9K | EDGAR |
| 2022-08-24 | — | Disp (D) | −100,000 | -$623.0K | |
| 2022-06-22 | SVRA | Buy (P) | +100,000 | $138.4K | EDGAR |
| 2022-01-14 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-30 | SVRA | Buy (P) | +50,000 | $64.0K | EDGAR |
| 2021-12-17 | SVRA | Buy (P) | +40,000 | $44.5K | EDGAR |
| 2021-12-14 | SVRA | Grant (A) | — | $0 | EDGAR |
| 2021-12-13 | SVRA | Buy (P) | +35,000 | $36.4K | EDGAR |
| 2021-12-09 | SVRA | Buy (P) | +25,000 | $26.2K | EDGAR |
| 2021-12-06 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +24,500 | $92.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.